TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
GENinCode UK Ltd. ( (GB:GENI) ) has provided an announcement.
GENinCode Plc announced that all resolutions were passed at their Annual General Meeting held in Oxford, UK. This development underscores the company’s continued focus on advancing its predictive genetics technology in the prevention of cardiovascular disease and ovarian cancer, potentially strengthening its market position and stakeholder confidence.
More about GENinCode UK Ltd.
GENinCode Plc is a UK-based company specializing in genetic risk assessment for cardiovascular disease and ovarian cancer. The company operates in the UK, Europe, and the United States, providing predictive technology that combines clinical algorithms and AI bioinformatics to offer preventive care and treatment strategies.
Average Trading Volume: 678,420
Technical Sentiment Signal: Sell
Current Market Cap: £6.45M
Learn more about GENI stock on TipRanks’ Stock Analysis page.